StockData
Mereo BioPharma Group plc logo

Mereo BioPharma Group plc (MREO) stock

MREONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 1/30
$0.26−0.02 (-5.45%)

Close on Nov 20, 2026Market cap $41.52MP/E –Yield –

Mereo BioPharma price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Mereo BioPharma's price to sales ratio was 85.6× on Apr 30, 2026.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Apr 30, 202685.6×−357.0
2025Jan 31, 2025442.5×+387.4
2024Jul 31, 202455.1×–

More Mereo BioPharma figures

See a number that looks wrong?